Does albumin use reduce 30-day mortality in intensive care patients with acute heart failure?
Albumin use may be associated with lower 30-day mortality in intensive care patients with acute heart failure, particularly in older males and those with HFrEF.
In conclusion, our investigation suggests that the use of albumin was associated with lower 30-day mortality in patients with acute heart failure, especially in males, those aged >75 years, those with HFrEF, those with higher N-terminal pro-brain natriuretic peptide levels, and those without sepsis.
Yu et al. (Mon,) studied this question.